UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000025856
Receipt number R000029698
Scientific Title Phase 1 study to evaluate the safety of dasatinib in relapsed and refractory angioimmunoblastic T-cell lymphoma
Date of disclosure of the study information 2017/01/30
Last modified on 2018/07/31 13:07:42

No. Disposal Last modified on Item of update
1 Insert 2017/01/26 13:59:52
2 Update 2017/07/14 16:55:11 Recruitment status
3 Update 2018/07/31 13:07:42 Recruitment status
Anticipated trial start date
Last follow-up date